BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹375 Cr | ₹335 Cr | ₹320 Cr | ₹311 Cr | ₹261 Cr |
What is the latest Total Liabilities ratio of BAL PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹375 Cr |
| Mar2025 | ₹335 Cr |
| Mar2024 | ₹320 Cr |
| Mar2023 | ₹311 Cr |
| Mar2022 | ₹261 Cr |
How is Total Liabilities of BAL PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹375 Cr | 11.77 | |
| Mar2025 | ₹335 Cr | 4.83 | |
| Mar2024 | ₹320 Cr | 2.84 | |
| Mar2023 | ₹311 Cr | 19.37 | |
| Mar2022 | ₹261 Cr | - | |
Compare Total Liabilities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹170.9 Cr | 15.8% | 22.7% | 22.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 15.8% |
22.7% |
22.4% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses